These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 406137)

  • 1. Diurnal variation of valproic acid plasma levels and day-night reversal in monkey.
    Lockard JS; Levy RH; DuCharme LL; Congdon WC; Patel IH
    Epilepsia; 1977 Jun; 18(2):183-9. PubMed ID: 406137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent kinetics III: diurnal oscillations in steady-state plasma valproic acid levels in rhesus monkeys.
    Levy RH; Lockard JS; Patel IH; Congdon WC
    J Pharm Sci; 1977 Aug; 66(8):1154-6. PubMed ID: 408478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal oscillations of CSF valproate in monkey.
    Lockard JS; Viswanathan CT; Levy RH
    Life Sci; 1985 Apr; 36(13):1281-5. PubMed ID: 3920464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy testing of valproic acid compared to ethosuximide in monkey model: I. Dosage regimen design in the presence of diurnal oscillations.
    Levy RH; Lockard JS; Patel IH; Lai AA
    Epilepsia; 1977 Jun; 18(2):191-203. PubMed ID: 406138
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy testing of valproic acid compared to ethosuximide in monkey model: II. Seizure, EEG, and diurnal variations.
    Lockard JS; Levy RH; Congdon WC; DuCharme LL; Patel IH
    Epilepsia; 1977 Jun; 18(2):205-24. PubMed ID: 406139
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronopharmacokinetics of valproic acid following constant-rate administration in mice.
    Ohdo S; Nakano S; Ogawa N
    Chronobiol Int; 1991 Feb; 8(1):35-43. PubMed ID: 1814601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding.
    Arens TL; Pollack GM
    Biopharm Drug Dispos; 2001 Sep; 22(6):243-9. PubMed ID: 11754040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid: reversibly acting drug?
    Lockard JS; Levy RH
    Epilepsia; 1976 Dec; 17(4):477-9. PubMed ID: 826396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.
    Loiseau P; Cenraud B; Levy RH; Akbaraly R; Brachet-Liermain A; Guyot M; Morselli PL
    Clin Pharmacokinet; 1982; 7(6):544-52. PubMed ID: 6819106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent interaction between phenytoin and valproic acid.
    Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
    Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent kinetics II: Diurnal oscillations in steady-state plasma ethosuximide levels in rhesus monkeys.
    Patel IH; Levy RH; Lockard JS
    J Pharm Sci; 1977 May; 66(5):650-3. PubMed ID: 406379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.
    Gugler R; Mueller G
    Br J Clin Pharmacol; 1978 May; 5(5):441-6. PubMed ID: 350249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronopharmacological study of sodium valproate in mice: dose-concentration-response relationship.
    Ohdo S; Nakano S; Ogawa N
    Jpn J Pharmacol; 1988 May; 47(1):11-9. PubMed ID: 3137385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of melatonin in the plasma of the rhesus monkey (Macaca mulatta).
    Jenkin G; Mitchell MD; Hopkins P; Matthews CD; Thorburn GD
    J Endocrinol; 1980 Mar; 84(3):489-94. PubMed ID: 6771354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin--valproic acid interaction in rhesus monkey.
    Koch KM; Ludwick BT; Levy RH
    Epilepsia; 1981 Feb; 22(1):19-25. PubMed ID: 6781887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variation of Valproic acid pharmacokinetics in mice.
    Ben-Cherif W; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA
    Eur J Pharm Sci; 2013 Jul; 49(4):468-73. PubMed ID: 23707469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronopharmacological study of valproic acid in mice: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ohdo S; Ogawa N
    J Pharmacobiodyn; 1992 Aug; 15(8):403-8. PubMed ID: 1479540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: an interspecies comparison.
    Hendrickx AG; Nau H; Binkerd P; Rowland JM; Rowland JR; Cukierski MJ; Cukierski MA
    Teratology; 1988 Oct; 38(4):329-45. PubMed ID: 3149039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of feeding schedule on the chronopharmacological aspects of sodium valproate in mice.
    Ohdo S; Ogawa N; Nakano S; Higuchi S
    J Pharmacol Exp Ther; 1996 Jul; 278(1):74-81. PubMed ID: 8764337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.